Arena Pharmaceuticals, (ARNA) Posts Wider than Expected Q4 Loss of 16c/Share

March 14, 2012 4:11 PM EDT
Get Alerts ARNA Hot Sheet
Trade ARNA Now!
Join SI Premium – FREE
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.49 million.

For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment